British drug major AstraZeneca’s Farxiga (dapagliflozin) oral tablets can now be used in the United States to treat chronic kidney disease regardless of diabetes status. The U.S. Food and Drug
Continue reading »Home »
US To Share AstraZeneca Covid-19 Vaccine With Rest Of The World
The United States plans to share millions of doses of AstraZeneca’s Covid-19 vaccine with the rest of the world, the White House has announced. “Given the strong portfolio of vaccines
Continue reading »AstraZeneca finds no evidence COVID vaccine raises blood clot risk
More On: COVID vaccine COVID-19 vaccine may ease long-term virus symptoms: report Andrew Cuomo’s outrageous new low is fresh reason he needs to go now US hits world record in
Continue reading »AstraZeneca cashed out Moderna stake for $1 billion in 2020
More On: pharmaceuticals Merck to help Johnson & Johnson produce COVID vaccine FDA panel OKs Johnson & Johnson single-dose COVID vax Sanofi, GSK start new COVID-19 vaccine study after failed
Continue reading »AstraZeneca, FibroGen: FDA To Convene Committee Meeting To Review Roxadustat In Anaemia Of CKD
AstraZeneca Plc. (AZN.L,AZN) announced Tuesday that the US Food and Drug Administration or FDA informed FibroGen, Inc. that it will convene a meeting of the Cardiovascular and Renal Drugs Advisory
Continue reading »AstraZeneca shares fall after efficacy findings for Covid-19 vaccine
AstraZeneca shares fell after the drugmaker announced efficacy results for its Covid-19 vaccine that were below those reported by rivals Pfizer/BioNTech and Moderna. The shares were down 3.5% at £80.29
Continue reading »Astrazeneca Says Covid Vaccine 70% Effective; To Seek Early Approval
AstraZeneca Plc and Oxford University’s coronavirus vaccine candidate AZD1222 is found to be 70 percent effective on average against Covid-19, according to the British pharmaceutical giant. AstraZeneca plans to immediately
Continue reading »AstraZeneca hopes to deliver COVID-19 vaccine in January
Save articles for later Add articles to your saved list and come back to them any time. AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of
Continue reading »China Vaccine Frontrunner Says Shots Are Safe Amid Astra Setback
China National Biotec Group Co. said none of the recipients of its two coronavirus shots has reported an obvious adverse reaction or infection, as the Chinese vaccine front-runner presses ahead
Continue reading »AstraZeneca may expose coronavirus vaccine participants to pathogen
The chief executive of AstraZeneca, which is developing a leading coronavirus vaccine with Oxford University, said it is too early to deliberately expose trial participants to the pathogen, but it
Continue reading »